Our Company

Our Company

Reprise Biomedical, Inc. is focused on the development and commercialization of biologic medical devices utilizing a proprietary perfusion decellularization process that delivers superior clinical outcomes in a wide variety of surgical procedures. Reprise commenced operations in 2019 as a spin-out from Miromatrix Medical under proprietary technology licensed from the University of Minnesota.

Our Approach

Reprise is led by an experienced medical device management team with a record of success in commercializing biologic medical devices, guided by a Board of Directors with a proven track record of business success.


Reprise is built on a culture of individual empowerment and individual responsibility that emphasizes the clinical outcomes to our physician customers and their patients with the products we develop and commercialize.

Carrie Powers

President and Chief Executive Officer

Steve Jagodzinski

Controller and Treasurer

Greg Smock

General Counsel and Chief Compliance Officer

Jake Isenburg, Ph.D.

Vice President of Research and Development

Jerrod Krueger

Vice President of Manufacturing

Heather Kotila

Vice President of Human Resources

Reprise Biomedical

Board of Directors

Guiding our mission to business success with integrity.